Century Therapeutics Inc
NASDAQ:IPSC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Century Therapeutics Inc
NASDAQ:IPSC
|
US |
|
Most Kwai Chung Ltd
HKEX:1716
|
HK |
Cash Flow Statement
Cash Flow Statement
Century Therapeutics Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(54)
|
(62)
|
(70)
|
(83)
|
(96)
|
(115)
|
(123)
|
(127)
|
(131)
|
(125)
|
(127)
|
(129)
|
(137)
|
(133)
|
(131)
|
(130)
|
(127)
|
(22)
|
(23)
|
(26)
|
(10)
|
|
| Depreciation & Amortization |
1
|
2
|
3
|
3
|
4
|
4
|
5
|
7
|
8
|
10
|
12
|
12
|
13
|
13
|
14
|
14
|
13
|
13
|
13
|
13
|
13
|
|
| Stock-Based Compensation |
1
|
1
|
2
|
4
|
5
|
7
|
8
|
10
|
11
|
12
|
13
|
14
|
15
|
14
|
14
|
14
|
13
|
12
|
11
|
8
|
7
|
|
| Other Non-Cash Items |
5
|
5
|
4
|
5
|
7
|
9
|
10
|
12
|
13
|
14
|
17
|
17
|
26
|
26
|
19
|
18
|
12
|
10
|
12
|
17
|
7
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
4
|
|
| Cash Interest Paid |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
6
|
(1)
|
1
|
(3)
|
(4)
|
122
|
121
|
122
|
123
|
(1)
|
3
|
15
|
9
|
4
|
1
|
(14)
|
(8)
|
(116)
|
(117)
|
(115)
|
(115)
|
|
| Cash from Operating Activities |
(41)
N/A
|
(57)
-37%
|
(63)
-12%
|
(78)
-23%
|
(89)
-14%
|
20
N/A
|
13
-35%
|
13
-2%
|
14
+11%
|
(102)
N/A
|
(96)
+6%
|
(85)
+11%
|
(88)
-4%
|
(89)
-1%
|
(98)
-10%
|
(112)
-15%
|
(110)
+2%
|
(115)
-4%
|
(114)
+0%
|
(112)
+2%
|
(104)
+7%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(15)
|
(14)
|
(19)
|
(30)
|
(45)
|
(47)
|
(47)
|
(41)
|
(31)
|
(32)
|
(26)
|
(19)
|
(14)
|
(9)
|
(5)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
(8)
|
(124)
|
(132)
|
(268)
|
(253)
|
(176)
|
(152)
|
12
|
17
|
94
|
82
|
57
|
75
|
51
|
5
|
36
|
48
|
64
|
131
|
117
|
108
|
|
| Cash from Investing Activities |
(23)
N/A
|
(138)
-505%
|
(151)
-10%
|
(299)
-98%
|
(298)
+0%
|
(223)
+25%
|
(199)
+11%
|
(29)
+85%
|
(13)
+55%
|
62
N/A
|
57
-9%
|
38
-33%
|
61
+60%
|
42
-32%
|
1
-98%
|
35
+4 216%
|
47
+34%
|
63
+34%
|
130
+105%
|
116
-11%
|
108
-7%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
160
|
384
|
383
|
384
|
251
|
27
|
27
|
27
|
1
|
1
|
1
|
1
|
18
|
75
|
75
|
75
|
57
|
(0)
|
(0)
|
0
|
|
| Net Issuance of Debt |
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
38
|
72
|
72
|
72
|
34
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
48
N/A
|
241
+406%
|
466
+93%
|
456
-2%
|
418
-8%
|
251
-40%
|
27
-89%
|
27
+2%
|
27
N/A
|
1
-97%
|
(9)
N/A
|
(9)
+2%
|
(10)
-5%
|
8
N/A
|
75
+858%
|
75
0%
|
75
0%
|
57
-24%
|
(0)
N/A
|
(0)
-52%
|
0
N/A
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
(16)
N/A
|
47
N/A
|
252
+436%
|
79
-68%
|
30
-62%
|
48
+57%
|
(160)
N/A
|
10
N/A
|
28
+172%
|
(39)
N/A
|
(48)
-24%
|
(56)
-16%
|
(37)
+34%
|
(40)
-7%
|
(22)
+44%
|
(2)
+92%
|
12
N/A
|
5
-55%
|
15
+186%
|
3
-79%
|
4
+17%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(56)
N/A
|
(70)
-26%
|
(82)
-17%
|
(108)
-32%
|
(134)
-24%
|
(27)
+80%
|
(34)
-25%
|
(28)
+17%
|
(17)
+42%
|
(133)
-706%
|
(121)
+9%
|
(104)
+14%
|
(102)
+2%
|
(98)
+4%
|
(103)
-5%
|
(112)
-9%
|
(110)
+2%
|
(116)
-5%
|
(115)
+0%
|
(113)
+2%
|
(105)
+7%
|
|